CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker); Clone Ber-H2 & CD30/412 (Concentrate)
Immunogen: Cancer cell line established from a patient with Hodgkin's disease of T-cell lineage (Ber-H2); human CD30 recombinant protein (CD30/412)
Clone: Ber-H2 & CD30/412
Isotype: IgG1, kappa (Ber-H2); IgG1, kappa (CD30/412)
Species Reactivity: Human. Others not known.
Positive Control: Hodgkin's lymphoma
Specificity: Recognizes a single chain glycoprotein of 105/120kDa, identified as CD30/Ki-1. This MAb distinguishes large cell lymphomas derived from activated lymphoid cells from histiocytic malignancies and lymphomas derived from resting and precursor lymphoid cells or from anaplastic carcinomas.